Tag: BIA-ALCL

All

Complete Surgical Excision Is the Most Effective Treatment for BI-ALCL

An MD Anderson-led study finds surgery improves survival, reduces recurrence in BI-ALCL.

Breast Implant-Related ALCL May Not Be Separate Entity
The FDA Requests Allergan Voluntarily Recall Natrelle BIOCELL Textured Breast Implants and Tissue Expanders from the Market to Protect Patients
Most American Women Have Never Heard of Breast Implant-Related Lymphoma
FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma
Breast Implants After Mastectomy Associated with Very Low Risk of Lymphoma

All

Sorry, No Posts Found

All

FDA Issues Complete Response Letter for AbbVie’s Fast-Acting Toxin Application

Agency requests additional manufacturing information and does not cite safety or efficacy concerns or require new clinical studies.

Sorry, No Posts Found